Clinical Trial Update: Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial protocol evaluating the addition of Icaritin soft capsules to TACE plus immunotherapy and targeted therapy for unresectable hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Icaritin (icaritin)

Snippet

Sponsor: Zhiyong Huang | Conditions: Unresectable Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING